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Expansion of G4C2 repeats in the C9ORF72 gene is the most prevalent inherited form of
amyotrophic lateral sclerosis and frontotemporal dementia. Expanded transcripts undergo
repeat-associated non-AUG (RAN) translation producing dipeptide repeat proteins from all
reading frames. We determined cis-factors and trans-factors inﬂuencing translation of the
human C9ORF72 transcripts. G4C2 translation operates through a 5′–3′ cap-dependent
scanning mechanism, requiring a CUG codon located upstream of the repeats and an initiator
Met-tRNAMeti. Production of poly-GA, poly-GP, and poly-GR proteins from the three frames
is inﬂuenced by mutation of the same CUG start codon supporting a frameshifting
mechanism. RAN translation is also regulated by an upstream open reading frame (uORF)
present in mis-spliced C9ORF72 transcripts. Inhibitors of the pre-initiation ribosomal complex
and RNA antisense oligonucleotides selectively targeting the 5′-ﬂanking G4C2 sequence block
ribosomal scanning and prevent translation. Finally, we identiﬁed an unexpected afﬁnity of
expanded transcripts for the ribosomal subunits independently from translation.
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Amyotrophic lateral sclerosis (ALS) and frontotemporaldementia (FTD) are devastating neurodegenerative dis-orders with a considerable clinical and pathological
overlap, which is further substantiated by the discovery of
C9ORF72 repeat expansions as the most frequent genetic cause
for both diseases1,2. Indeed, expansion of a G4C2 hexanucleotide
repeat in the ﬁrst intron of the C9ORF72 gene is identiﬁed in
~40% and ~25% of familial ALS and FTD, respectively, as well as
5% of sporadic patients3. The number of G4C2 repeats is normally
lower than 30 and can extend to several hundred repeats in
patients. As in other microsatellite diseases, C9ORF72 expansions
are transcribed from both sense and antisense strands (reviewed
in ref. 4). Bidirectional transcription of the C9ORF72 locus results
in the production of transcripts containing either G4C2 or C4G2
repeats that accumulate into RNA foci1,5–10. The G4C2-contain-
ing RNAs were proposed to form G-quadruplex secondary
structures and sequester several RNA-binding proteins (RBPs)
including hnRNP H1/F, ALYREF, SRSF2, hnRNPA1, hnRNPA3,
ADARB2, Pur-α, and Nucleolin (reviewed in ref. 4). In addition,
C9ORF72 expanded transcripts are translated into dipeptide
repeat (DPR) proteins through unconventional translation,
known as repeat-associated non-AUG (RAN) translation11. RAN
translation occurs in absence of an AUG start codon, in multiple
reading frames of the same repeat-containing transcript, and
within coding as well as non-coding regions12. This mechanism
has now been described in several microsatellite expansion dis-
eases, including spinocerebellar ataxia type 8 (SCA8)11, myotonic
dystrophy (DM1 and DM2)11,13, Huntington’s disease (HD)14,
fragile X-associated tremor/ataxia syndrome (FXTAS)15, spino-
cerebellar ataxia type 3116, and C9ORF72 ALS/FTD10,17–20. Both
G4C2 sense and C4G2 antisense transcripts are translated from the
three coding frames into ﬁve DPR proteins, which aggregate in
C9ORF72 ALS/FTD patients10,13,18–21. Poly-Glycine-Alanine
(poly-GA) and poly-Glycine-Arginine (poly-GR) are translated
from the sense strand G4C2 transcripts, while poly-Proline-
Alanine (Poly-PA) and poly-Proline-Arginine (poly-PR) are
produced from the antisense strand C4G2 RNA. Poly-Glycine-
Proline (poly-GP) may be produced from both RNA strands.
These DPR proteins are the main components of cytoplasmic
p62-positive, TDP-43-negative aggregates that represent a unique
pathological hallmark in C9ORF72 ALS/FTD patients22,23. Evi-
dence supports that DPR proteins, in particular arginine-rich
poly-GR and poly-PR proteins, are toxic and play a central role in
neurodegeneration due to C9ORF72 expansions (reviewed in ref.
24).
However, how RAN translation of C9ORF72 expanded tran-
scripts occurs and which factors are required is unknown.
Translation initiation of canonical mRNAs is a complex process
that requires numerous eukaryotic initiation factors (eIFs) and is
crucial for regulation of gene expression. The 40S ribosomal
subunit binds to the 5′ cap and then scans along the mRNA until
encountering an initiation codon. Most of the regulation is
exerted at the ﬁrst stage, where the AUG start codon is identiﬁed
and decoded by the methionyl-tRNA specialized for initiation
(Met-tRNAMeti)25. The efﬁciency of start codon selection is
strongly inﬂuenced by surrounding sequences and the recruit-
ment of eIFs. Certain viral and cellular messenger RNAs escape
the canonical translation pathway to attract the ribosomes in a
cap-independent scanning mechanism. These RNAs contain
highly structured sequence, called internal ribosome entry site
(IRES), mimicking initiation factors to directly recruit the ribo-
some at the start codon26,27. Repeat-containing RNAs may also
adopt stable structures, such as stem loops or G-quadruplexes and
an IRES-like mechanism could be at the origin of RAN transla-
tion in microsatellite expansion diseases12,28–32. Against this
hypothesis, RAN translation of CGG repeats associated with
FXTAS was recently shown to involve a canonical cap-dependent
scanning mechanism33. The cis-factors and trans-factors inﬂu-
encing the translation of the human C9ORF72 expansion tran-
scripts are not yet identiﬁed. Determining whether
hexanucleotide G4C2 transcripts recruit the ribosome following
the canonical translation initiation or using an IRES mechanism
is a crucial step for the development of therapeutic approaches
targeting RAN translation in C9ORF72 ALS/FTD patients.
Herein, we provide mechanistic insights delineating the dif-
ferent steps needed to recruit the ribosome and initiate RAN
translation from G4C2 expansions to produce poly-GA, GP, and
GR proteins. Similar to a canonical mechanism of translation34,
the production of DPR proteins from expanded transcripts
requires a 5′cap insertion, involves the initiator methionine and
strongly relies on sequences upstream of the repeat. G4C2 RAN
translation proceeds by a 5′–3′ canonical scanning mechanism to
start translation at a near-cognate CUG codon and produce DPR
proteins by frameshifting. Consistent with this mechanism, we
also demonstrate that G4C2 RAN translation is downregulated by
an upstream open reading frame (uORF) present in abnormally
spliced C9ORF72 transcripts35. Inhibitors of the pre-initiation
ribosomal complex and RNA antisense oligonucleotides (ASOs)
targeting the sequence upstream of the repeats inhibit G4C2 RAN
translation, conﬁrming a scanning-dependent mechanism that
may be targeted for therapeutic intervention. Finally, G4C2-con-
taining RNAs are found to be associated with ribosomal subunits
in a translation independent manner supporting a new RNA gain
of function mechanism in C9ORF72 disease.
Results
Translation efﬁciency of G4C2 RAN translation. To identify cis-
factors and trans-factors inﬂuencing the translation of G4C2
repeats in the context of the C9ORF72 gene, we used a construct
containing 66 repeats that was shown to undergo RAN transla-
tion in all three frames when expressed in cultured cells and in
the mouse central nervous system20,36. This construct was
modiﬁed to generate a series of vectors with different sequences
ﬂanking the repeat at the human C9ORF72 locus (Supplementary
Fig. 1 and Table 1). Sequences encoding for a speciﬁc tag in each
of the three reading frames were inserted downstream of the
repeat to monitor the production of poly-GA (HA in the +1
frame), poly-GP (His in the +2 frame), and poly-GR (FLAG in
the +3 frame). RAN translation from all three reading frames is
therefore examined from the same G4C2 construct.
A cell-free translation assay based on rabbit reticulocyte lysates
(RRL) was developed to monitor RAN translation efﬁciency from
C9ORF72 transcripts. In vitro RAN translation was observed in
all three frames from capped RNAs with 66 repeats (Fig. 1a–c,
Supplementary Fig. 2a). To accurately compare the translation
efﬁciency of the repeat in each frame, we used as reference Renilla
luciferases with either HA, His, or FLAG tags under the control of
the intergenic region (IGR) IRESs from cricket paralysis virus
(CrPV). IRES are structural RNA elements that allow ribosome
hi-jacking and trigger translation in a cap-independent man-
ner26,27. Among them, IGR promotes highly efﬁcient translation
without any AUG start codon, does not need eIF or the initiator
tRNAMeti37,38, and was shown to be efﬁciently translated in
RRL39. Indeed, canonical translation under the 5’UTR of the β-
globin is only one fold more efﬁcient than translation under the
control of the IGR (Supplementary Fig. 2b–d). We compared the
efﬁciency of C9ORF72 RAN translation in the three reading
frames with the translation of tagged-luciferase reporter mRNAs
that are controlled by the CrPV IGR. A striking difference in
translation efﬁciency was observed between the three frames.
Indeed, translation of the capped (G4C2)66 mRNA in the +1 poly-
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GA frame was 17 times more efﬁcient than the IGR-luciferase
reporter (Fig. 1a, d). In contrast, translation efﬁciency from poly-
GP in the +2 frame and poly-GR in the +3 frame was equivalent
to the translation of IGR-luciferase (Fig. 1b–d). Notably, poly-GA
aggregates are the most prevalent DPR proteins accumulated in
post-mortem brain samples from C9ORF72 ALS/FTD patients
(Supplementary Fig. 3)17,40 supporting that translation of the
C9ORF72 repeat is most efﬁcient in the +1 frame both in vitro
and in vivo.
We also uncovered that the size of the expansion does not
equally inﬂuence translation of the different frames. Production
of poly-GP in the +2 frame was strongly inﬂuenced by the size of
the repeat when comparing 30 and 66 repeats (Fig. 1b, f,
Supplementary Fig. 1; constructs #3 vs. #4). In contrast, no
signiﬁcant difference was observed for poly-GA or poly-GR,
which were equally expressed from both 30 and 66 G4C2 repeats
(Fig. 1a, c, e, g).
Cap-dependent G4C2 translation initiates with methionine.
Our in vitro assay provided the opportunity to determine whether
RAN translation of the C9ORF72 repeat depends on the presence
of a 5′m7G cap. Levels of poly-GA produced from 66 repeats
increased more than ﬁve times when transcripts were capped
(Fig. 1a, e) and poly-GP/GR syntheses were strongly repressed in
absence of the cap, supporting a canonical cap-dependent
mechanism of translation for all three DPR proteins (Fig. 1a, b,
c, e, f, g).
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Fig. 1 G4C2 RAN translation is length dependent and displays different efﬁciencies across reading frames. RNA transcripts with (G4C2)30 or (G4C2)66
repeats were transcribed in vitro with T7 RNA polymerase, capped or not capped and subjected to translation in rabbit reticulocyte lysate (RRL) system.
Increasing RNA concentrations (100 and 200 nM) were used for translation in RRL. RAN translation was probed on immunoblot with antibodies to (a) HA
tag in the +1 poly-GA frame, (b) His tag in the +2 poly-GP frame, and (c) FLAG tag in the + 3 poly-GR frame. Schematics of constructs with 30 repeats (#3)
and 66 repeats (#4) are shown in Figure S1. (d) Efﬁciencies of RAN translation in the different frames were measured relatively to Renilla Luciferase with
the corresponding tags driven by the intergenic region (IGR) IRES from the cricket paralysis virus. The efﬁciencies of RAN translation from capped RNAs
were compared to uncapped RNAs at 100 nM for (e) poly-GA, (f) poly-GP, (g) poly-GR with 30 or 66 G4C2 repeats, relatively to the capped 66 repeats.
Graphs represent mean± SEM, n= 3. Student’s t-test, *p≤ 0.05; **p≤ 0.01; ***p≤ 0.001
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Canonical translational initiation consists of base-pairing
between the initiator Met-tRNAMeti anticodon and the AUG
start codon. The incorporation of [35S]-methionine during the
translation of transcripts expressing 30 repeats (#3) or 66 repeats
(#4) was measured to determine whether RAN translation
requires Met-tRNAMeti for the production of DPR proteins
(Fig. 2a, b). Notably, the sequence of the transcripts #3 and #4 do
not contain any AUG codon and the presence of [35S]-
methionine in RAN products cannot derive from the incorpora-
tion of an internal methionine (Supplementary Fig. 1 and
Table 1). A speciﬁc [35S]-methionine band was detected at the
expected 14.5 and 20.5 kDa molecular weight from constructs
expressing 30 and 66 repeats, respectively (Fig. 2b). The level of
[35S]-methionine labeled polypeptide(s) was proportional to RNA
concentration indicating that RAN translation is observed in sub-
saturating conditions. Immunoprecipitation of poly-GA products
with a HA-speciﬁc antibody conﬁrmed that RAN translation
initiates with the incorporation of a methionine residue (Fig. 2c).
To further demonstrate that G4C2 RAN translation starts with a
methionine, we inhibited the activity of the methionylated
initiator tRNAMet carrier eIF2 by inducing the phosphorylation
of its α subunit with poly(I:C)/salubrinal treatment as previously
described41 (Supplementary Fig. 4a). While this treatment did not
have any impact on the non-canonical translation of IGR-renilla
luciferase, it inhibited the translation of a capped-dependent
renilla luciferase reporter and the incorporation of [35S]-
methionine in DPR products (Supplementary Fig. 4b).
To gain further insights in the mechanism of RAN translation,
we investigated the requirement of eukaryotic initiation factor
eIF4E. In canonical translation the cap binding protein eIF4E is
part of a larger complex called eIF4F, which also contains the
platform protein eIF4G and the RNA helicase eIF4A34 (Fig. 2d).
To test whether eIF4E is involved in the RAN translation of G4C2
repeats we monitored the translation efﬁciency in the presence of
an excess of cap analog (m7GpppG) or its non-functional ApppG
counterpart. The competition assay was performed in RRL
(Fig. 2e, f) and wheat germ extract (WGE) (Supplementary
Fig. 4c, d), a highly cap-dependent system42. Increasing
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Fig. 2 G4C2 RAN translation is cap-dependent and initiates with a methionine. (a) Schemes of the RNA with (G4C2)30 (#3) or (G4C2)66 (#4) repeats that
were transcribed in vitro with T7 RNA polymerase, capped and subjected to translation in RRL. (b) Translation was performed in the presence of [35S]-
methionine and capped RNA #3 or #4 at 100 and 200 nM. RAN translation products were detected by autoradiography. Asterisk indicates bands in the
stacking gel. (c) Translation was performed in presence of [35S]-methionine and capped RNA #4 followed by immunoprecipitation with antibody against
HA-tag and detection of immunoprecipitated [35S]-methionine proteins by autoradiography. (d) Scheme of the canonical translation involving the cap-
binding protein eukaryotic initiation factor 4E (eIF4E), the protein platform (eIF4G) and the helicase (eIF4A) that recruit the 40S ribosomal subunit. This
pre-initiation complex scans the 5′ of the transcript for an appropriate start codon. Compounds used for the competition assay in (e) and (f) are
represented by dark circles and squares for the cap analog (m7GpppG) and the inactive form (ApppG), respectively. (e–f) Translation was performed in
presence of [35S]-methionine, capped (G4C2)66 RNA #4 and an increased concentration of inactive cap (control, ApppG) or cap analog (competitor of the
cap, m7GpppG). [35S]-methionine RAN translation products and poly-GA were detected by (e) autoradiography and (f) immunoblot with an antibody
against HA-tag, respectively
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concentrations of cap analog, but not ApppG, lead to eIF4E
titration thereby affecting the efﬁciency of eIF4F-dependent
translation. The levels of [35S]-methionine-DPRs (Fig. 2e,
Supplementary Fig. 4c) and poly-GA accumulation (Fig. 2f,
Supplementary Fig. 4d) were reduced by increased concentrations
of cap analog, demonstrating the role of the canonical initiation
factor eIF4E in C9ORF72 RAN translation.
G4C2 translation initiates at a near-cognate CUG start codon.
We next sought to identify the codon(s) used to initiate transla-
tion of C9ORF72 transcripts (Fig. 3a). The presence of a single
band on SDS-PAGE for the different DPR products (Fig. 1),
corroborated by [35S]-methionine labeling (Fig. 2), suggests that
the translation of G4C2 starts at a speciﬁc position. In addition,
in vitro RAN translation products obtained from 66 repeats had
the same estimated molecular weight of 20.5 kDa in all three
frames (Fig. 1a–c) suggesting that translation in the different
frames is initiated from a single or neighboring start codons.
A candidate start site is a near-cognate CUG codon located 24
nucleotides upstream of the repeats in the +1 frame and
embedded in a perfect Kozak sequence43 (G/A in −3 and G in
+4) (Supplementary Fig. 1, Fig. 3b, and Supplementary Table 1).
Site-directed mutagenesis of this codon from CUG to CCG was
sufﬁcient to abolish the production of [35S]-methionine labeled
DPR proteins in RRL, demonstrating that this CUG is used as
start codon to translate C9ORF72 G4C2 repeats (Fig. 3b, c;
construct #4 vs. #5). In contrast, a point mutation from GAG to
GGG in another putative start site located 13 nucleotides
upstream of the repeats in the +2 frame only slightly reduced
the level of [35S]-methionine DPR proteins (Fig. 3b, c; construct
#4 vs. #7). Transcripts containing mutations at both putative start
codons conﬁrmed the necessity of the CUG codon to initiate
RAN translation of the C9ORF72 repeat (Fig. 3b, c; construct #4
vs. #6). This was further corroborated by using constructs with 5′
truncations either preserving the near cognate CUG codon (#8)
or deleting the entire region (#9) (Fig. 3b, c; construct #8 vs. #9).
Importantly, immunoblot analyses revealed that syntheses of all
three DPRs, poly-GA, poly-GP, and poly-GR, are equally disabled
by the CUG mutation located 24 nucleotides upstream of the
repeats (Fig. 3d; construct #4 vs. #5). In contrast, mutation of the
GAG codon located 13 nucleotides upstream of the repeats
reduced the levels of the three DPRs without abolishing their
production (Fig. 3d; construct #4 vs. #7). Site-directed mutagen-
esis of the near cognate CUG codon to a canonical start codon
AUG increases the incorporation of [35S]-methionine in DPR
products (Fig. 3b, e; construct #10 vs. #4) and concomitantly the
level of DPRs from all three frames, poly-GA, poly-GP, and poly-
GR (Fig. 3b, f; construct #10 vs. #4). Interestingly, mutating the
Kozak sequence inhibits the production of DPR proteins detected
by [35S]-methionine autoradiography (Fig. 3b, e; construct #11 vs.
4 5 6 7 8 9
25
35S-Met autoradiography
Anti-HA
(GA)
Anti-His
(GP)
Anti-FLAG
(GR)
Immunoblot
?
25
25
25
START codon 4E
4G 4A
Met
CAU
40S
*
kDa
4 5 6 7 8 9
– 24 nt
– 13 nt
Constructs
– 24 nt
– 13 nt
Constructs
Identification of translation initiation codon
*
#4
86 nt
6 nt
Near-cognate start codon
in perfect Kozak sequence
+4–3
Constructs
HA
66
66
66
66
66
66
66
66
His FLAG
+1
(GA)
+2
(GP)
+3
(GR)
#5
#6
#7
#8
#9
Cap
#10
#11
10
AUG
4
CUG
11
CUG
Constructs
–3G/+4G –3U/+4C –3G/+4G
35S-Met autoradiography
Immunoblot
Anti-HA
(GA)
Anti-His
(GP)
Anti-FLAG
(GR)
10
AUG
4
CUG
11
CUG
Constructs
Kozak
– 24 nt
Kozak
– 24 nt
–3G/+4G –3U/+4C –3G/+4G
25
25
25
*
*
25
kDa
35S-Met
DPRs
35S-Met
DPRs
kDa
kDa
a
c e
d f
b
66
Fig. 3 G4C2 RAN translation of all reading frames initiates at the same near-cognate CUG start codon in RRL. (a) Scheme of the pre-initiation complex
loaded at the 5′cap and the 40S ribosomal subunit ready to scan toward the start codon. RAN translation occurs in absence of an AUG codon. (b) Schemes
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#4), as well as immunoblots for poly-GA, poly-GP, and poly-GR
(Fig. 3b, f; construct #11 vs. #4). This striking result demonstrates
that RAN translation producing DPR proteins from the three
frames starts at the same CUG codon, and implies that
production of poly-GP and poly-GR requires frameshifting
events, +1 and −1, respectively. An additional smaller poly-GA
product was translated from construct #7 suggesting that
mutation of GAG to GGG induces another translation initiation
event further downstream in frame +1 that is less efﬁcient than
initiation at CUG. The frameshifting necessary to produce +2
(poly-GP) and +3 (poly-GR) DPR proteins might explain the
yield of DPR productions observed in Fig. 1 and patient tissues
(Supplementary Fig. 3). Indeed, poly-GA translated from the +1
frame is the predominant DPR protein, poly-GP and poly-GR
require one frameshifting event (−1 or + 1) and are therefore
signiﬁcantly less produced.
The crucial role of the CUG translation initiation codon
located 24 nucleotides upstream of the C9ORF72 repeat was
further conﬁrmed in vivo by expressing 66 repeats with either a
CUG codon (construct #4) or its mutated CCG version (construct
#5) in human neural progenitor cells (ReNcell VM)44, mouse
motor neuron-like cells (NSC-34), and human embryonic kidney
293T cells (HEK293T) (Fig. 4). Immunoblots using antibodies
that recognize each DPR protein identiﬁed products at a
comparable molecular weight in the three cell types and RRL
demonstrating similar RAN translation of the wild-type construct
(#4) in all systems (Figs. 3 and 4). RAN translation of poly-GA
and poly-GP was abolished by mutation of the CUG codon in
human neural progenitors (Fig. 4b, c, Supplementary Fig. 5a, b;
construct #4 vs. #5) and motor neuron-like cells (Fig. 4d, e;
construct #4 vs. #5), conﬁrming results observed in RRL (Fig. 3;
construct #4 vs. #5). RAN translation of poly-GR could not be
detected with any of the constructs in these cell lines. As shown in
RRL experiments (Fig. 3), G4C2 RAN translation in the poly-GA
+1 frame and the poly-GR +3 frame was also abolished by
mutation of the CUG codon in HEK293T cells (Fig. 4f, g,
Supplementary Fig. 5d; construct #4 vs. #5). However, in contrast
to RRL and the two neuronal models, mutating the CUG codon
did not inhibit production of poly-GP in HEK293T cells but
instead induced a 20% increase detected by antibodies recogniz-
ing either poly-GP (Fig. 4f, g; Supplementary Fig. 5e; construct #4
vs. #5) or the HIS tag (Supplementary Fig. 5c). This observation
supports that poly-GP translation from an alternative start site
may be inﬂuenced in HEK293T by additional trans-acting factor
(s) that are absent in RRL, motor neuron-like NSC-34 and neural
progenitor cells. Overall, these results identify a mechanism
where cap-dependent translation of the C9ORF72 G4C2 repeat
requires Met-tRNAMeti to initiate translation in all reading frames
at a near-cognate CUG codon located upstream of the expansion.
An uORF represses G4C2 translation. Recently, Niblock et al.
identiﬁed poly-adenylated C9ORF72 RNA species that retain the
repeat-containing intron 1 and in which downstream exons are
correctly spliced35. This ﬁnding opens the possibility that G4C2
RAN translation occurs from a C9ORF72 mRNA variant with an
enlarged 5′-untranslated region containing the G4C2 repeats.
Notably, retention of intron 1 creates a potential uORF with 55
codons ﬂanked by an AUG start codon and two consecutive stop
codons (UGA and UAA) (Supplementary Fig. 1 and Table 1).
Emerging evidence suggests that the presence of uORF may
regulate the expression of downstream ORF25,45,46. Indeed,
translation of uORFs located in the 5′UTRs of transcripts often
inhibits translation of the downstream ORF likely by reducing its
accessibility to the preinitiation complex47,48. Hence, we tested
whether the uORF created by the retention of intron 1 in
C9ORF72 transcripts may inﬂuence RAN translation of DPR
proteins (Fig. 5a). We generated a construct with 66 repeats and
the entire 5′ end sequence of C9ORF72 starting with exon 1A
(Fig. 5b, Supplementary Fig. 1; construct #1). The uORF was
found to strongly repress RAN translation in all frames of
C9ORF72 repeat. Indeed, [35S]-methionine labeled DPR proteins
were not detected in presence of the uORF (Fig. 5c, construct #1
vs. #4). Immunoblot analysis conﬁrmed the inﬂuence of the
uORF with a severe reduction of poly-GA (+1 frame) levels and
non-detectable poly-GP (+2) and poly-GR (+3) products (Fig. 5d;
construct #1 vs. #4). Mutation of the uORF AUG start codon into
CGG (Fig. 5b, construct #2) restored G4C2 RAN translation from
all reading frames conﬁrming its role in repressing RAN trans-
lation (Fig. 5c, d; construct #2 vs. #1). Overall, these ﬁndings
strongly support that RAN translation operates through a 5′–3′
scanning mechanism and is regulated by an uORF in C9ORF72
transcripts that retain intron 1.
5′–3′ scanning-dependent mechanism for G4C2 translation. To
further demonstrate that RAN translation uses a canonical 5′–3′
scanning mechanism we investigated whether the eIF4A, an RNA
helicase required for efﬁcient scanning during translation initia-
tion, is involved in G4C2 RAN translation (Fig. 6a–e). FL3, an
eIF4A-speciﬁc inhibitor49, was found to reduce RAN translation
in RRL as demonstrated by the levels of [35S]-methionine labeled
DPR proteins (Supplementary Fig. 6a,b; construct #4) and poly-
GA (Fig. 6b, Supplementary Fig. 6c; construct #4) generated from
two different concentrations of expanded RNAs. Consistently,
FL3 treatment signiﬁcantly reduced the levels of poly-GA, poly-
GP, and poly-GR in HEK293T (Fig. 6c, d) without affecting the
level of the repeat-containing transcripts (Fig. 6e). To conﬁrm the
role of eIFs and a 5′–3′scanning mechanism in RAN translation,
we used a longer transcript that includes exon 1a and the entire
intronic region upstream of the C9ORF72 repeat with a AUG>
CGG mutation in the uORF start codon (Supplementary Fig. 6a;
construct #2). Consistent with our previous results, production of
DPR proteins was partially restored in presence of the mutated
uORF, but was strongly inhibited after treatment with FL3
(Supplementary Fig. 6a–c; construct #2). Another important
component for scanning is the platform eIF4G, which links the
cap binding factor eIF4E with the small ribosomal subunit
(Fig. 6a). To investigate whether eIF4G is required for G4C2 RAN
translation we used 4EIRCat, an inhibitor that prevents the direct
interaction between eIF4E and eIF4G50. Consistently, synthesis of
poly-GA from two different RNA concentrations was also
reduced by 4EIRCat (Fig. 6b). Finally, we found that both edeine
and cycloheximide completely inhibited the RAN translation
from all three reading frames (Fig. 6b, Supplementary Fig. 6b–d).
Edeine is a translation inhibitor that prevents the interaction of
Met-tRNAMeti anticodon with the start codon in the P site of the
ribosome (Fig. 6a). Cycloheximide binds between the E site and
P site of the ribosome and thereby blocks translocation to the
next codon (Fig. 6a)51. The profound effect of these inhibitors on
RAN translation is consistent with our previous results showing
that G4C2 RAN translation uses a canonical translation
mechanism and initiates at a CUG codon with Met-tRNAMeti
anticodon interaction in the P site of the ribosome (Figs. 2–4).
Overall, the effect of speciﬁc translation inhibitors on the pro-
duction of DPR proteins demonstrate that G4C2 RAN translation
requires eIF4F components (4E, 4G and 4A) to promote efﬁcient
cap-dependent 5′–3′ scanning.
Inhibition of G4C2 translation by RNA ASOs. We previously
showed that DNA ASOs targeting sense strand G4C2-containing
transcripts mediate their cleavage through action of the primarily
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nuclear enzyme RNase H, reducing the level of RNA foci and
DPR proteins in a C9ORF72 transgenic mouse model and patient
ﬁbroblasts7,52. To determine whether RNA ASOs targeting the 5′
ﬂanking G4C2 sequence can block the scanning of ribosomes and
inhibit RAN translation without inducing RNAse-H-dependent
degradation, we generated ASOs selectively targeting the region
upstream of the repeats and tested their potency in inhibiting
G4C2 RAN translation in RRL system (Fig. 6f–h). One RNA
C9ORF72 ASO (RNA-ASO1) was complementary to a sequence
that overlaps the near-cognate CUG codon, and two ASOs (RNA-
ASO2, RNA-ASO3) were chosen to cover sequences located at 41
and 82 nucleotides distal from the repeats, respectively (Fig. 6f).
Corresponding RNA sense oligonucleotides (RNA-SOs) were
used as controls (RNA-SO1, RNA-SO2, and RNA-SO3, Fig. 6f).
All three RNA-ASOs induced a dose-dependent reduction of
DPR proteins produced from the capped G4C2 66 repeats RNAs
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as measured by [35S]-methionine-labeling (Fig. 6g) and immu-
noblot (Fig. 6h). In contrast, SO controls did not affect the levels
of DPR proteins. These results demonstrate that RNA ASOs
targeting the 5′ ﬂanking G4C2 sequence are sufﬁcient to block
RAN translation independently of C9ORF72 RNAs degradation
and identify the 5′–3′ scanning of ribosomes as a potential ther-
apeutic target in C9ORF72 ALS/FTD.
G4C2 RNAs bind ribosomes independently from translation.
To assess ribosome loading onto (G4C2)exp RNAs, we performed
sucrose gradient analysis with radiolabeled capped RNAs con-
taining either 30 or 66 repeats. As a control for canonical
translation we used radiolabelled capped human β-globin mRNA.
Radiolabeled capped RNAs with 66 antisense C4G2 repeats were
also used as control for RAN translation (Fig. 7a). Sucrose gra-
dient analysis with 30 and 66 G4C2 repeat transcripts showed that
RNA-containing repeats are mainly associated with polysomes
(Fig. 7a, b green graph, Supplementary Fig. 6e orange graph;
heavy fractions 0–20). Only a small proportion of RNAs was free
(RNP; ribonucleoproteins), associated with the ribosomal small
subunit in complex with initiation factors (48S) or with mono-
somes (80S), which is consistent with active RAN translation
(Fig. 1). Since transcripts containing expanded repeats, including
G4C2 RNAs, were recently shown to undergo abnormal phase
transition and form gel-like structures in vitro53, we determined
whether the presence of radiolabeled G4C2 RNAs in the heavy
fractions could be due to self-aggregation rather than association
with polyribosomes. Against this possibility, G4C2-free RNAs
remained in the light fractions of sucrose gradients strongly
supporting that expanded RNAs associate with polyribosomes in
RRL. Contrary to the sense (G4C2)66 RNAs, transcripts
containing the antisense (C4G2)66 repeat sedimented mainly in
the light fractions or were associated to monosomes, consistent
with a low translation efﬁciency of the antisense transcripts
(Fig. 7a, b; blue graph)40. Unexpectedly, treatment with edeine,
that blocks the translation (Fig. 6b) and lead to the accumulation
of β-globin mRNA in the light fractions (Fig. 7c, Supplementary
Fig. 6f; light fractions 20–40, red graphs), did not prevent loading
of polysomes on transcripts with 66 or 30 G4C2 repeats (Fig. 7c,
Supplementary Fig. 6f; heavy fractions 0–20, green and orange
graphs). The same abnormal sedimentation of G4C2 transcripts in
heavy fractions was observed after treatment with GMP-PNP, a
non-hydrolysable GTP analog that normally leads to the accu-
mulation of the transcripts in the fraction corresponding to the
48S particles, showing that G4C2 RNAs can recruit ribosomes in a
translation-independent manner (Supplementary Fig. 6g). As
expected, blocking ribosomal translocation with cycloheximide
induced the accumulation of the control β-globin mRNAs in the
fraction corresponding to monosomes 80S that are prevented
from translocating after assembly (Fig. 7d, Supplementary Fig. 6h;
red graphs). In contrast, inhibiting RAN translation with cyclo-
heximide (Fig. 6b, Supplementary Fig. 6b–d) did not prevent
ribosomal loading on expanded transcripts with 30 or 66 repeats
(Fig. 7d, Supplementary Fig. 6h; heavy fractions 0–20, green and
orange graphs). As expected the 80S peak was slightly increased
consistent with a small proportion of expanded G4C2 RNAs being
associated with monosomes after cycloheximide treatment, but
most transcripts remained present in the heavy fractions despite
cycloheximide blockage of translation. Notably, radiolabeled
(G4C2)66 transcripts were more abundant in heavy fractions when
they were folded in presence of K+ ions that stabilize G-
quadruplex structures, comparatively to Na+ and Li+ ions (Sup-
plementary Fig. 6i). Finally, to conﬁrm that G4C2 RNAs recruit
1 2 4
35S-Met
DPRs
AUG
4
25
35S-Met autoradiography
1 2
Anti-HA
(GA)
Anti-His
(GP)
Anti-FLAG
(GR)
Immunoblot
HA
66
66
66
His FLAG
+1
(GA)
+2
(GP)
+3
(GR)
#1 AUG UGAuORF
#2 CGG UGAuORF
#4
Constructs 
Cap
171 nt 55 nt
1a 1b
113 nt
GUC 
80S
(GGGGCC)66UGAAUG uORF
Enhancing
or inhibiting
RAN translation
Cap
25
25
25
CGG ΔAUG
?
Regulation by a short upstream open reading frame
kDa
kDa
a c
d
b
Fig. 5 RAN translation of G4C2 repeats is down-regulated by a short upstream open reading frame (uORF). (a) Retention of intron 1 in C9ORF72 repeat-
containing transcripts creates an uORF located 226 nucleotides upstream of the start CUG codon. This uORF may inhibit or enhance G4C2 RAN translation.
(b) To interrogate the regulation of RAN translation by this uORF, RNAs harboring the 5′ full-length sequence including C9ORF72 exon 1A (#1) and a
AUG> CCG mutation in the uORF start codon (#2) were compared to RAN translation from RNA without the uORF (#4). Black boxes represent exons 1a
and 1b and the gray box represents the uORF overlapping exon 1a and intron 1. (c) Translation in RRL system was performed in presence of [35S]-
methionine and capped RNA (#1, #2, or #4) followed by detection of [35S]-methionine proteins by autoradiography. (d) Poly-GA, poly-GP, and poly-GR
were detected by immunoblots using antibodies against HA-tag, His-tag, and FLAG-tag, respectively
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-02643-5
8 NATURE COMMUNICATIONS |  (2018) 9:152 |DOI: 10.1038/s41467-017-02643-5 |www.nature.com/naturecommunications
the ribosome independently from DPR translation, we performed
sucrose gradient analysis with puriﬁed ribosomal 40S and 60S.
Expanded transcripts with 30 repeats were able to recruit and
load several 40S and 60S ribosomal subunits without the need of
5′-cap and any other initiation factors (Fig. 7e). Overall, we
demonstrate here that G4C2 repeat-containing transcripts
associate with ribosomal subunits independently of translational
factors.
Discussion
G4C2 hexanucleotide expansions in the C9ORF72 gene were
recently discovered as the major genetic cause of ALS and FTD,
two fatal neurodegenerative disorders1,2. Emerging evidence
supports pathogenic RNA gain-of-function mechanisms, where
expanded G4C2 transcripts form RNA foci sequestering RNA-
binding proteins in the nuclei or undergo RAN translation to
produce toxic DPR proteins4. We developed robust assays to
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study RAN translation and determine speciﬁc cis-requirements
and trans-requirements for expanded G4C2 translation. G4C2
RAN translation was found to share many aspects with canonical
translation initiation, including the requirement of a 5′ cap
structure, methionylated initiator tRNAMet, and the recruitment
of the 40S subunit by the eIF4F complex (eIF4A, E, and G) to
begin scanning toward the start codon (Fig. 8a, b). These ﬁndings
are consistent with mechanisms involved in RAN translation of
CGG triplet repeats in the fragile X FMR1 gene which also
depends on a cap-dependent scanning mechanism15,33,54.
Since eIF4F’s functions were shown to be critical in dysregulation
of the translational machinery in cancers, major efforts have been
undertaken to develop speciﬁc compounds directed against its
components for therapeutic purposes55. Our work highlights the
importance of eIF4F in ALS/FTD pathogenesis, thereby opening
the potential for new therapeutic strategies using existing eIF4F
inhibitors to mitigate the effects of this neurodegenerative disease.
Ribosome proﬁling on higher eukaryotes showed that trans-
lation occurs on numerous ORFs without an AUG-initiator but
operates with near-cognate start codons (CUG>GUG>UUG>
ACG> others)56,57. We discovered that the CUG codon located
24 nucleotides upstream of the G4C2 repeat, in the +1 (GA) frame
and in an optimal Kozak sequence, is utilized as a start codon to
produce DPR proteins. Mutations of this CUG codon or the
Kozak sequence abolish production of all three DPR proteins in
RRL supporting a frameshifting model where the ribosome starts
at the CUG and slips to translate GP (+2) and GR (+3) (Fig. 8b).
As in RRL, RAN translation in all three frames was affected by
mutation of the CUG codon in human neural progenitor, mouse
motor neuronal cells and HEK293T cells. However, while poly-
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GP translation was prevented by mutation of the CUG repeat in
RRL and the two neuronal models, poly-GP levels were slightly
increased in HEK293T cells supporting a context-dependent
regulation that differs between the three frames when the CUG is
absent. The presence of speciﬁc RNA helicases might explain the
differences on poly-GP translation between the different cell
types, such as DDX21 recently shown to unfold RNA G-
quadruplex structures in HEK293T58. Notably, an UAG stop
codon in phase with the poly-GP frame is present at the begin-
ning of the G4C2 repeats (UAG GGG CC sequence, Supple-
mentary Fig. 1), indicating that the ribosome must initiate in
another reading frame and then frameshift to produce poly-GP or
directly initiate within the repeat. As we observed a single band
on SDS-PAGE with comparable molecular weight between all
reading frames and systems used (Figs. 3 and 4), initiation further
downstream inside the repeats is less likely to occur from
(G4C2)66 transcripts. When comparing translation efﬁciencies for
the three reading frames, poly-GA (+1) is predominant, followed
by poly-GP (+2) and poly-GR (+3), which is in agreement with a
frameshifting model. This is also consistent with staining and
immunoassay from human post-mortem tissues, where poly-GA
accumulates at higher levels than poly-GP and poly-GR (Sup-
plementary Fig. 3)17,40,59,60.
G4C2 RAN translation initiation is inﬂuenced by repeat length,
with different sensitivity among the three reading frames. While
RAN translation efﬁciency is only reduced in the +1 poly-GA and
+3 poly-GR frames with shorter repeat length, it is completely
abolished for poly-GP at 30 comparatively to 66 repeats (Fig. 1).
This repeat length dependence could reﬂect secondary structures,
which differentially affect ribosomal scanning, translation
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Fig. 8 Model of translation mechanisms associated with G4C2 expansions in C9ORF72 ALS/FTD. (a) Pre-Initiation ribosomal complex (PIC) assembles on
the 5′ cap of mRNA by interacting with eIF4F complex formed by the cap binding factor eIF4E, the platform eIF4G and the RNA helicase eIF4A. The PIC
complex scans the 5′ end for an appropriate AUG start codon, where the 60S ribosomal subunit joins the 40S to form a functional 80S ribosome ready to
translate the coding sequence. (b) G4C2 RAN translation initiation shares the same pathway as the canonical one to translate poly-GA dipeptides, including
the need of 5′ cap, eIF4E, eIF4G, eIF4A, initiator methionyl-tRNA, and the scanning mechanism. However, it initiates on a near-cognate CUG codon
embedded in a perfect Kozak sequence, in frame with poly-GA, instead of a canonical AUG start codon. The ability of G4C2 expansions to form stable G-
quaduplex structures forces the ribosome to occasionally undergo frameshifting to translate poly-GP and poly-GR in the +2 and +3 frames, respectively. (c)
When G4C2 repeats are expanded, a subset of C9ORF72 mRNA is mis-spliced retaining intron 1 with the repeats35. RAN translation from these RNAs is
inhibited by a uORF that is translated canonically. (d) G4C2 expanded transcripts associate with ribosomal subunits independently from their translation
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elongation or force the ribosome to undergo a frameshifting.
Indeed, G4C2 expansions can adopt RNA G-quadruplexes28–32, a
structure that was recently demonstrated to induce frameshifting
during translation61,62. These RNA secondary structures are
stable in presence of monovalent cations, in the order of K+>
Na+> Li+ 63. Thus, variations of ion concentration in the cell or
speciﬁc RNA binding proteins58 may modulate the presence of G-
quadruplex structure in G4C2-containing transcripts and could
inﬂuence frameshifting or initiation at non-AUG start codon.
Another major ﬁnding is the down-regulation of G4C2 RAN
translation by a short uORF. Indeed, in mis-spliced C9ORF72
transcripts that retain intron 1, an uORF is present with an AUG
and two in-frame stop codons located 76 nucleotides upstream of
the G4C2 repeats. Notably, the AUG codon in exon 1A is the only
AUG identiﬁed in the 5′end of the mis-spliced RNA. Upstream
ORF are cis-acting elements that regulate the expression of
downstream protein coding sequences25,45,46. We demonstrated
that mutating the AUG start codon of the uORF is sufﬁcient to
increase G4C2 RAN translation in all three reading frames, con-
ﬁrming that this uORF is efﬁciently used by the ribosome during
5′–3′ scanning and is therefore inhibiting the translation of the
downstream G4C2 repeat (Figs. 5 and 8c). It is noteworthy that
translation of synaptic mRNA(s) was shown to be downregulated
by uORF(s) located in their 5′UTR, but upregulated upon
metabotropic glutamate receptor activation64–66. Thus, it will be
important to determine whether the uORF in mis-spliced
C9ORF72 transcripts inﬂuences G4C2 RAN translation level
upon synaptic activation or external stimuli in neurons.
Notably, ASOs directing RNase-H-dependent degradation of
C9ORF72 transcripts are under therapeutic development5–7,52.
The identiﬁcation of sequences upstream of the repeat that
inﬂuence RAN translation (CUG near-cognate start codon and
uORF) opens the possibility of using alternative strategies based
on ASOs that modulate translation without reducing transcript
levels67,68. In agreement, we demonstrated that several RNA
ASOs speciﬁcally targeting the region immediately upstream of
the repeats block ribosomal scanning and efﬁciently reduce the
level of RAN translation products (Fig. 6f–h).
Finally, we show that G4C2 repeat transcripts unexpectedly
associate with ribosomal subunits in a translation independent
manner (Fig. 8d). Indeed, blocking cap initiation factors,
codon–anticodon interaction, 80S ribosome assembly and ribo-
somal elongation did not avert the sedimentation of radiolabeled
G4C2 RNAs in the heavy fractions of sucrose gradients (Fig. 7). In
addition, removing the 5′cap, shortening the repeat size, or using
puriﬁed ribosomal subunits did not prevent the assembly of the
transcript to multiple ribosomal subunits. On the contrary,
antisense transcripts with C4G2 repeat did not associate with the
ribosome. This striking ﬁnding supports a RNA gain-of-function
mechanism, independent from RAN translation and DPR pro-
teins accumulation. Ribosomal subunits are assembled in the
nucleolus and exported to the cytoplasm by multiple export
receptors69. It will be important to determine whether seques-
tration of ribosomal subunits by expanded repeats and disruption
of nucleocytoplasmic transport recently identiﬁed in C9ORF72
disease4 negatively impact overall translation in cells with
C9ORF72 expansions.
Overall, we provide new insights into RAN translation of
C9ORF72 G4C2 repeat which uses a cap-dependent mechanism
initiating at a near-cognate CUG codon. A novel mechanism of
toxicity associated to C9ORF72 expansion is supported by the
association of G4C2 transcripts with ribosomal subunits inde-
pendently of their translation. Importantly, this work identiﬁes
sequences upstream of the G4C2 repeats and speciﬁc initiation
factors as possible therapeutic targets to inhibit RAN translation
in C9ORF72 ALS/FTD patients.
Methods
Generation of C9ORF72 constructs with G4C2 repeats. To generate the different
constructs listed in Supplementary Fig. 1 and Table 1, a plasmid pAG3 containing
66 repeats20,36 was ﬁrst digested with restriction sites BssHII and SacI to isolate the
intronic region of human C9ORF72 with (G4C2)66, including 8 bp of 5′, 99 bp of 3′
ﬂanking sequences and three tags in frame with DPR proteins. BssHII is a
restriction site naturally present in the human C9ORF72 gene located two
nucleotides upstream of the repeats. Second, pUC18 (ThermoFisher, # SD0051)
was modiﬁed to contain the three HindIII, BssHII, and SacI restriction sites,
enabling the insertion of the digested BssHII/SacI C9ORF72 insert and the addition
of any 5′end sequence between the HindIII and BssHII sites. After cloning the
C9ORF72 insert in modiﬁed pUC18 with BssHII and SacI, primers listed in Sup-
plementary Table 2 were used to generate the different constructs listed in Sup-
plementary Fig. 1. Primers were designed to add the T7 Promoter for in vitro
transcription (construct #9), followed immediately by 113 bp of 5′ ﬂanking G4C2
sequence with CUG >CCG mutation (construct #5), GAG>GGG mutation
(construct #6) and double mutations CUG>CCG + GAG>GGG (construct #7).
Also, primers were designed to add T7 promoter followed by 320 bp of 5′ sequence
(construct #1), 320 bp with AUG >CGG mutations (construct #2) and to generate
a short 5′end by adding T7 promoter with 33 bp (construct #8). All primers were
designed to harbor the HindIII restriction site at the 5′ end and BssHII site at the 3′
end. After phosphorylation with T4 Polynucleotide Kinase (ThermoFisher,
#EK0031) of the primers at the 5′end and hybridization of corresponding forward
and reverse primers, the generated inserts were cloned in HindIII-BssHII pUC18
with (G4C2)66 repeats. The original plasmid was modiﬁed to contain T7 promoter
by cloning using the HindIII restriction site (construct #4). Construct #3 with 30
G4C2 repeats was generated by expansion retraction during ampliﬁcation of the
construct #4 with 66 repeats. Finally, construct #5 containing CUG>CCG
mutation was digested with HindIII and NotI to be cloned in pAG3 downstream of
the CMV early enhancer/chicken β-actin (CAG) promoter for human cell
transfection.
The C4G2 antisense construct used as control in Fig. 7 was cloned by digesting
pAG3 containing 66 repeats20,36 with restriction sites BssHII and NotI to isolate
the intronic region of human C9ORF72 with (G4C2)66 and cloning it into puc18
harboring T7 promoter in antisense direction. This construct was designed to
harbor Flag tag in poly-PR +1 frame and HA tag in +3 poly-PA frame.
In vitro transcription. The different variants of C9ORF72 (G4C2)exp constructs
were cloned downstream of T7 promoter in pUC18 as detailed in Supplementary
Fig. 1 and Table 1. Vectors were digested by XhoI and used for run-off in vitro
transcription with T7 RNA polymerase. Uncapped RNAs were separated on
denaturing PAGE (4%) and RNA were recovered from the gel slices by electro-
elution. The resulting pure RNA transcripts were capped at their 5′ end with the
ScriptCap m7G Capping System (Epicenter Biotechnologies).
In vitro translation in RRL. Translation reactions were performed in self-made
rabbit reticulocyte lysate system (RRL) as previously described42, without RNase
treatment (used in commercially available extracts) that was shown to be detri-
mental to the translation efﬁciency from extracts, especially for cap-dependent
translation70. Brieﬂy, reactions were incubated at 30 °C for 60 min and included
100 and 200 nM of each transcript and 10.8 µCi [35S]Met. Aliquots of translation
reactions were analyzed by 15% SDS-PAGE and Western Blots. The cap depen-
dency was analyzed by preincubation of increasing m7GpppG concentrations
ranging from 0.5 to 1.5 mM for 5 min at room temperature. The experiments were
performed in the presence of MgCl2 at a constant [MgCl2]/[cap analog] ratio of 0.8.
For translation in presence of RNA sense (RNA-SO) and antisense (RNA-ASO)
oligonucleotides (Supplementary Table 3) were annealed to 100 nM capped 66
repeat RNA (construct #4) in 20 mM Hepes-K (pH 7.6) and 100 mM KC1 for 5
min at 65 °C and 20 min at room temperature with a 10 or 50 fold molar excess of
oligonucleotides over construct #4. This annealing mixture was kept on ice before
addition to the translation reaction. RRL were incubated 5 min at 30 °C in presence
of the different translational inhibitors at the following concentrations: 150 ng mL
−1 for the polyI:C, 15 μM for salubrinal, 4.5 mg mL−1 cycloheximide, 10 μM edeine,
15 μM FL3, and 5 μM 4E1RCat.
Sucrose-gradient analysis. For sucrose-gradient analysis, 5′-32P-labeled or 3′-32P-
labeled mRNA were incubated in RRL or with puriﬁed 40S and 60S ribosomal
subunits, in the presence of speciﬁc inhibitors (Edeine leads to 43S accumulation,
GMP-PNP leads to 48S formation, cycloheximide blocks translocation and leads to
80S accumulation) or without inhibitor to assemble polysomes. Translational
inhibitors were incubated with RRL 5min prior to addition of radiolabeled
mRNAs. The translation initiation complexes were separated on a 7–47% linear
sucrose gradient in buffer (25 mM Tris–HCl [pH 7.4], 50 mM KCl, 5 mMMgCl2, 1
mM DTT). The reactions were loaded on the gradients and spun (23,411×g for 2.5
h at 4 °C) in a SW41 rotor. mRNA sedimentation on sucrose gradients was
monitored by Cerenkov counting after fractionation. In Supplementary Fig. 6i,
capped (G4C2)66 transcripts were folded in presence of KCl, NaCl or LiCl at 195
mM, by denaturating 1 min at 95 °C, followed by 5 min at 20 and 4 °C until adding
the RRL (75 mM ﬁnal ion concentrations).
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Cell culture and plasmid transfection. The HEK293T cells were cultured in
DMEM 10% (v/v) FBS and penicillin/streptomycin. ReNcell VM human neural
progenitors (Millipore; Catalog number SCC008) were maintained in high-glucose
DMEM/F12 (ThermoFisher Scientiﬁc) media supplemented with 2 μg mL−1
heparin (StemCell Technologies, #07980), 2% (v/v) B27 neural supplement
(ThermoFisher Scientiﬁc, #175004044), 20 μg mL−1 hEGF (Sigma-Aldrich,
#E9644), 20 μg mL−1 bFGF (Stemgent, #03-0002) and 1% penicillin/streptomycin
(ThermoFisher Scientiﬁc) and were plated onto BD Matrigel (BD Biosciences)-
coated cell culture ﬂasks with B27, EGF, FGF, and heparin on precoated Matrigel
dishes. The NSC-34 cells (CELLutions Biosystems Inc; Catalog number—CLU140)
were grown in DMEM supplemented with 10% FBS, 100 UmL−1 penicillin, and
100 μg mL−1 streptomycin at 37 °C in a humidiﬁed atmosphere of 5% CO2.
HEK293T were plated 24 h prior transfection with different C9ORF72 (G4C2)66
expansion constructs (Supplementary Fig.1 and Table 1) and a reporter pGFPmax
(Lonza) expressing GFP using a contruct:pGFPmax ratio of 5:1. The lipofectamine
2000 reagent was used according to manufacturer instruction (Invitrogen) for
HEK293T and NSC-34 transfections. Nucleofection using Nucleofector kit (Lonza,
#VPG 1005) was used for neural progenitor cell to achieve high efﬁciency of
transfection of plasmids. Twenty-four hours after transfection, the cells were
washed with PBS 1X and collected for RNA and protein extractions.
FL3 treatment in cells. HEK293T were cultured 24 h prior treatment into 10 cm
dish, following by transfection with lipofectamine 2000 of construct #4 as described
previously. After 4 h of incubation in the transfection reagents, cells were treated
with 10 μM FL3 for 24 h and collected for immunoblot analysis
Immunoblotting. The cell pellets were re-suspended in 400 μl of 2X Laemmli
sample buffer (Biorad #1610737). The proteins were homogenized with pestle, then
denatured at 95 °C for 10 min. The total protein extract was separated on gradient
4–20% SDS-PAGE gels and 18% SDS-PAGE gels, transferred onto PVDF mem-
branes, blocked with 5% (v/v) non fat dry milk (NFM) in Tris–buffered saline
(TBS) pH 7.5. The membranes were incubated with primary antibodies (Supple-
mentary Table 4) overnight at 4 °C in TBS and 5% (v/v) NFM, washed with TBS-
Tween 20 0.1%, incubated with horseradish peroxidase (HRP)-conjugated sec-
ondary antibodies (donkey anti-rabbit GE Healthcare Life Sciences #NA934, sheep
anti-mouse GE Healthcare Life Sciences #NA931, goat anti-rat abcam #97057),
washed with TBS-Tween 20 0.1% and signal was revealed with autoradiographic
ﬁlms.
Immunoﬂuorescence. HEK293T cells were cultured on 24-well plates prior
transfection with lipofectamine 2000, following the recommendations of supplier.
Twenty-four hours after transfection, the cells were ﬁxed in 4% paraformaldehyde
and washed twice with PBS. Cells were permeabilized with 0.1% Triton X-100 for
10 min at room temperature. They were washed twice again with PBS and blocked
with 1% bovine albumin in PBS for 1 h at room temperature. Cells were incubated
at 4 °C for 24 h with primary antibodies anti-GA or anti-GP (Supplementary
Table 4) at 1:500 dilution in the blocking solution supplemented with 0.02%
Tween-20. Rabbit ﬂuorescently tagged secondary antibody conjugated to Alexa 595
(ThermoFisher Scientiﬁc) was incubated for 1 h at room temperature in the
blocking buffer. The nuclei were stained with ProLong™ Gold Antifade Mountant
with DAPI (ThermoFisher, # P36935) and mounted on slides for confocal
microscopy.
Immunohistochemistry of human brain sections. Parafﬁn sections (8 μm) from
the cerebellum were deparafﬁnized with CitriSolv (Thermo Fisher Scientiﬁc, #04-
355-121) and incubated in 100% EtOH, 90% EtOH, 70% EtOH, 50%, and Milli-Q®
water. Sections were incubated in 0.6% H2O2 in methanol at room temperature for
15 min, treated with antigen unmasking solution (Vector Laboratories, #H-3300) in
the steam chamber for 45 min, and blocked at room temperature with 1% FBS/
0.1% Triton X-100/PBS for 25 min. Sections were then incubated at 4 °C overnight
with anti-GA rabbit antibody (Rb4334) (1:1000), anti-GR rabbit antibody (Rb4995)
(1:1000), or anti-GP rabbit antibody (Rb7633) (1:1000)52 diluted in 1% FBS/PBS.
Next, sections were stained with secondary antibody ImmPRESSTM HRP (per-
oxidase) anti-Rabbit IgG Reagent (Vector Laboratories, #MP-7401) at room tem-
perature for 1 h, developed with VECTOR NovaRED Peroxidase (HRP) Substrate
Kit (Vector Laboratories, #SK-4800), treated with hematoxylin stain solution
(RICCA, #3530-32) and bluing reagent Scott’s tap water substitute (Leica Biosys-
tems, #3802901), and mounted with Richard-Allan ScientiﬁcTM Mounting Medium
(Thermo Fisher Scientiﬁc, #4112).
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon request. All constructs and reagents generated
in this study will be shared upon request.
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